Evaluation of efficacy of buserelin plus nilutamide in Mexican Male patients with advanced prostate cancer

Statistics

Original article

Evaluación de la eficacia de buserelina más nilutamida en pacientes mexicanos con cáncer prostático avanzado

R.F. Velázquez-Macíasa,

Corresponding author

ravelma@urocirugia.com

Corresponding author at: San Faustino M842, L12, Pedregal Santa Úrsula, CP 04600 Ciudad de México, Mexico. Tel.: +52 5585810069.

, S. Aguilar-Patiñob, R. Cortez-Betancourtc, I. Rojas-Esquiveld, G. Fonseca-Reyese, N. Contreras-Gonzálezf

a Servicio de Urología, Hospital Regional Lic, Adolfo López Mateos, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Distrito Federal, Mexico

b Servicio de Urología, Hospital General Vasco de de Quiroga, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Morelia, Michoacán, Mexico

c Servicio de Urología, Centro Médico Nacional 20 de Noviembre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Distrito Federal, Mexico

d Servicio de Urología, Hospital Regional 1 de Octubre, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Distrito Federal, Mexico

e Servicio de Urología, Hospital Regional General Ignacio Zaragoza, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Distrito Federal, Mexico

f Servicio de Urología, Hospital General Tacuba, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Distrito Federal, Mexico

Read

3671

Times
was read the article

1097

Total PDF

2574

Total HTML

Share statistics

Article information

ISSN: 20074085
Original language: English

DOI:10.1016/j.uromx.2016.10.001

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 April	18	21	39
2024 March	22	3	25
2024 February	26	7	33
2024 January	76	13	89
2023 December	26	5	31
2023 November	67	14	81
2023 October	44	13	57
2023 September	33	7	40
2023 August	24	4	28
2023 July	18	7	25
2023 June	39	8	47
2023 May	42	5	47
2023 April	95	5	100
2023 March	34	4	38
2023 February	20	10	30
2023 January	16	11	27
2022 December	22	10	32
2022 November	32	5	37
2022 October	31	14	45
2022 September	15	22	37
2022 August	53	16	69
2022 July	23	9	32
2022 June	23	17	40
2022 May	26	8	34
2022 April	27	14	41
2022 March	45	7	52
2022 February	29	9	38
2022 January	42	7	49
2021 December	48	17	65
2021 November	45	21	66
2021 October	33	19	52
2021 September	25	16	41
2021 August	20	6	26
2021 July	14	9	23
2021 June	14	15	29
2021 May	15	5	20
2021 April	36	19	55
2021 March	60	7	67
2021 February	23	17	40
2021 January	14	13	27
2020 December	17	15	32
2020 November	14	9	23
2020 October	17	8	25
2020 September	19	22	41
2020 August	30	14	44
2020 July	28	18	46
2020 June	39	17	56
2020 May	22	12	34
2020 April	16	12	28
2020 March	44	13	57
2020 February	40	9	49
2020 January	35	11	46
2019 December	50	21	71
2019 November	25	22	47
2019 October	29	22	51
2019 September	29	11	40
2019 August	17	14	31
2019 July	17	11	28
2019 June	41	25	66
2019 May	70	56	126
2019 April	56	29	85
2019 March	31	17	48
2019 February	30	22	52
2019 January	30	3	33
2018 December	21	9	30
2018 November	39	13	52
2018 October	30	14	44
2018 September	56	12	68
2018 August	8	13	21
2018 July	13	3	16
2018 June	13	6	19
2018 May	12	10	22
2018 April	7	2	9
2018 March	10	2	12
2018 February	15	2	17
2018 January	13	3	16
2017 December	19	2	21
2017 November	15	6	21
2017 October	17	1	18
2017 September	24	8	32
2017 August	12	10	22
2017 July	10	6	16
2017 June	23	22	45
2017 May	19	15	34
2017 April	18	12	30
2017 March	26	34	60
2017 February	32	18	50
2017 January	18	7	25
2016 December	43	13	56
2016 November	0	2	2

Show all

Follow us:

Statistics

Subscribe to our newsletter